Category Archives: Indefiniteness

DC indefiniteness and invalidity findings affirmed as claims lack “reasonable certainty”

TVnGO Ltd. (BVI) v. LG Electronics, et al. Docket No. 2020-1837 (http://www.cafc.uscourts.gov/sites/default/files/opinions-orders/20-1837.OPINION.6-28-2021_1796547.pdf) (Non-precedential) PROST, SCHALL, REYNA June 28, 2021 Brief Summary:  DC indefiniteness and invalidity findings affirmed (no reasonable certainty). Summary:  TVnGO appealed DC finding that the claims of five … Continue reading

Posted in Claim Construction, Indefiniteness | Leave a comment

DC indefiniteness determination affirmed due to “inconsistent prosecution history statements”

Infinity Computer Products, Inc. v. OKI Data Americas, Inc. Docket No. 2020-1012 (http://www.cafc.uscourts.gov/sites/default/files/opinions-orders/20-1189.OPINION.2-10-2021_1730931.pdf) PROST, CLEVENGER, TARANTO February 10, 2021 Brief Summary:  DC indefiniteness determination affirmed due to “inconsistent prosecution history statements”. Summary:  Infinity appealed DC indefiniteness finding regarding US Pat. … Continue reading

Posted in Claim Construction, Indefiniteness, Prosecution History Estoppel | Leave a comment

DC claim construction and indefiniteness findings affirmed; ineligibility conclusions not reached by FC panel

Synchronoss Techs., Inc. v. Dropbox, Inc., Funambol, Inc. Docket No. 2020-2196, -2199 (http://www.cafc.uscourts.gov/sites/default/files/opinions-orders/19-2196.OPINION.2-12-2021_1732513.pdf) PROST, REYNA, TARANTO February 12, 2021 Brief Summary:  DC claim construction, invalidity for indefiniteness, and grant of SJ affirmed. Summary:  Synchronoss appealed DC claim constructions and grant … Continue reading

Posted in Claim Construction, Indefiniteness, Means-plus-function, Patent Eligibility (101), Section 101 (see also Patentability), Software | Leave a comment

DC grant of SJ of infringement to Lilly under DOE affirmed

Eli Lilly And Company v. Apotex, Inc. Docket No. 2020-1328 (http://www.cafc.uscourts.gov/sites/default/files/opinions-orders/20-1328.OPINION.12-21-2020_1705369.pdf) PROST, BRYSON, STOLL December 21, 2020 Non-precedential Brief Summary:  DC grant of SJ of infringement under DOE affirmed. Summary:  Apotex appealed DC grant of Lilly’s motion for summary judgment … Continue reading

Posted in Doctrine of equivalents, Generics / ANDA, Indefiniteness, Prosecution History Estoppel | Leave a comment

DC decision invalidating claims for indefiniteness of the term “half-liquid” affirmed

IBSA Institut Biochimique, S.A. et al. v. Teva Pharmaceuticals USA, Inc. Docket No. 2019-2400 PROST, REYNA, HUGHES July 31, 2020 Brief Summary: DC finding of invalidity for indefiniteness of the term “half-liquid” affirmed. Summary: IBSA appealed DC decision finding claims … Continue reading

Posted in Indefiniteness | Leave a comment

DC indefiniteness findings vacated and remanded (Nautilus standard controls, only general-purpose computer or processor requires a specific algorithm)

Nevro Corp. v. Boston Scientific Corp. et al. Docket No. 2018-2220, -2349 LOURIE, REYNA, HUGHES April 9, 2020 Brief Summary: DC grant of SJ based on its indefiniteness finding vacated and remanded (e.g., the correct standard is the Nautilus “reasonable … Continue reading

Posted in Indefiniteness | Leave a comment

Horizon’s petition for en banc rehearing regarding indefiniteness denied (four judges dissented regarding “consisting essentially of”))

HZNP Medicines LLC et al. v. Actavis Laboratories UT, Inc. Docket No. 2017-2149, -2152-53, -2202-3, -2206 PROST, NEWMAN, REYNA October 10, 2019 (update Feb. 25, 2020) Update (2/25/20): Petition for en banc hearing denied. Judges Lourie, Newman, O’Malley and Stoll … Continue reading

Posted in comprising, consisting of, Generics / ANDA, Indefiniteness | Leave a comment

Horizon’s OB ‘913 claim 12 survives obviousness challenge (Pennsaid® for osteoarthritis)

HZNP Medicines LLC et al. v. Actavis Laboratories UT, Inc. Docket No. 2017-2149, -2152-53, -2202-3, -2206 PROST, NEWMAN, REYNA October 10, 2019 Brief Summary: DC findings of indefiniteness, no induced infringement, and no invalidity for obviousness regarding Horizon’s OB patents … Continue reading

Posted in Claim Construction, Generics / ANDA, Indefiniteness, Inducement to Infringe, Infringement, Obviousness, Uncategorized | Leave a comment

ITC finding of no indefiniteness or invalidity for anticipation or obviousness affirmed

Guangdong Alison Hi-Tech Co. v. Int. Trade Comm. (ITC), Aspen Aerogels, Inc. Docket No. 2018-2042 DYK, CHEN, STOLL August 27, 2019 Brief Summary: ITC finding of no indefiniteness or invalidity for anticipation or obviousness affirmed. Summary: Guangdong Alison Hi-Tech Co. … Continue reading

Posted in Anticipation (35 USC 102), Indefiniteness, Inherency, International Trade Commission, Obviousness, Prosecution History Estoppel, Uncategorized | Leave a comment

Diebold Nixdorf, Inc. et al. v. Int. Trade Commission (ITC (Appellee)) / Hyosung TNS Inc. et al. (intervenors)

Docket No. 2017-2553 PROST, BRYSON, O’MALLEY August 15, 2018 Brief summary: ITC finding that Diebold violated § 337 by importing components of automated teller machines (“ATMs”) that infringe means-plus-function claims reversed as invalid for indefiniteness (§ 112, para. 6). Summary: … Continue reading

Posted in Indefiniteness, International Trade Commission, Means-plus-function | Leave a comment